1. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003; 290:2057–2060.
Article
2. Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, et al. Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology. 2017; 124:1753–1763.
3. Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, Ridker PM. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol. 2007; 125:300–305.
Article
4. Smith BT, Joseph DP, Grand MG. Treatment of neovascular age-related macular degeneration: past, present and future directions. Curr Opin Ophthalmol. 2007; 18:240–244.
Article
5. Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol. 1999; 6:125–143.
Article
6. van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005; 294:3101–3107.
Article
7. Park SJ, Kwon KE, Choi NK, Park KH, Woo SJ. Prevalence and incidence of exudative age-related macular degeneration in South Korea: a nationwide population-based study. Ophthalmology. 2015; 122:2063–2070.
Article
8. Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017; 120:229–243.
Article
9. Forouzandeh F, Salazar G, Patrushev N, Xiong S, Hilenski L, Fei B, et al. Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis. J Am Heart Assoc. 2014; 3:e001202.
Article
10. Kortekaas KE, Meijer CA, Hinnen JW, Dalman RL, Xu B, Hamming JF, et al. ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm. PLoS One. 2014; 9:e111952.
Article
11. Chrysant SG, Chrysant GS. The pleiotropic effects of angiotensin receptor blockers. J Clin Hypertens (Greenwich). 2006; 8:261–268.
Article
12. Ma L, Wang Y, Du J, Wang M, Zhang R, Fu Y. The association between statin use and risk of age-related macular degeneration. Sci Rep. 2015; 5:18280.
Article
13. Etminan M, Brophy JM, Maberley D. Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case-control study. Curr Drug Saf. 2008; 3:24–26.
Article
14. Shin JY, Choi NK, Jung SY, Kim YJ, Seong JM, Park BJ. Overlapping medication associated with healthcare switching among Korean elderly diabetic patients. J Korean Med Sci. 2011; 26:1461–1468.
Article
15. Cho GJ. Clinical research using medical big data. Anesth Pain Med. 2017; 12:9–14.
Article
16. National Health Insurance Service (NHIS). Manual of the National Health Insurance Service-National Elderly Cohort (NHIS-NEC), South Korea [Internet]. Wonju: NHIS;2017. accessed on 2018 March 12. Available at:
https://nhiss.nhis.or.kr/bd/ab/bdaba008cv.do.
17. Suissa S. The Quasi-cohort approach in pharmacoepidemiology: upgrading the nested case-control. Epidemiology. 2015; 26:242–246.
18. Smeeth L, Cook C, Chakravarthy U, Hubbard R, Fletcher AE. A case control study of age related macular degeneration and use of statins. Br J Ophthalmol. 2005; 89:1171–1175.
Article
19. Klein R, Klein BE, Tomany SC, Danforth LG, Cruickshanks KJ. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol. 2003; 121:1151–1155.
Article
20. Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN. Risk of macular degeneration in users of statins: cross sectional study. BMJ. 2001; 323:375–376.
Article
21. McGwin G Jr, Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. Br J Ophthalmol. 2003; 87:1121–1125.
Article
22. McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust. 2001; 175:340.
Article
23. McGwin G Jr, Xie A, Owsley C. The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology. 2005; 112:488–494.
Article
24. van Leeuwen R, Tomany SC, Wang JJ, Klein R, Mitchell P, Hofman A, et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology. 2004; 111:1169–1175.
Article
25. Thomas AS, Redd T, Hwang T. Effect of systemic beta-blockers, ACE inhibitors, and angiotensin receptor blockers on development of choroidal neovascularization in patients with age-related macular degeneration. Retina. 2015; 35:1964–1968.
Article
26. Sedgwick P. Nested case-control studies: advantages and disadvantages. BMJ. 2014; 348:g1532.
Article
27. Park BJ, Sung JH, Park KD, Seo SW, Kim SW. Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database. 1st ed. Seoul: Seoul National University;2003.